SAN CARLOS, Calif.--(BUSINESS WIRE)--Deltagen, Inc. (Pink Sheets: DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported financial results for the three months ended September 30, 2006 and declared a 20-cent per share dividend scheduled to be distributed on or about December 28, 2006 to shareholders of record as of the close of business on December 18, 2006.
